The GlaxoSmithKline newsletter covers the global consumer healthcare activities of GlaxoSmithKline during the first quarter of 2005.
Problems continue for GlaxoSmithKline. The company delivered a poor set of results for 2004. While this was said to be largely due to competition from generic medicines in the pharmaceutical sector, the company's 'promising' new product pipeline is not delivering products quick enough to fill this gap.
